Top Ranked Growth Stocks to Buy for February 26th

MOH EL SSNC

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, February 26th:

SS&C Technologies Holdings, Inc. (SSNC - Free Report) : This software products and software-enabled services provider to financial services providers, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.3% over the last 60 days.

SS&C Technologies Holdings, Inc. Price and Consensus

SS&C has a PEG ratio of 1.16, compared with 3.68 for the industry. The company possesses a Growth Score of B.

SS&C Technologies Holdings, Inc. PEG Ratio (TTM)

Molina Healthcare, Inc. (MOH - Free Report) : This Medicaid-related solutions provider, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.6% over the last 60 days.

Molina Healthcare, Inc Price and Consensus

Molina has a PEG ratio of 1.16, compared with 3.48 for the industry. The company possesses a Growth Score of B.

Molina Healthcare, Inc PEG Ratio (TTM)

The Estée Lauder Companies Inc. (EL - Free Report) : This manufacturer of consumer products such as skin care, hair care, fragrance and makeup etc, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.7% over the last 60 days.

The Estee Lauder Companies Inc. Price and Consensus

Estée Lauder has a PEG ratio of 2.55, compared with 2.92 for the industry. The company possesses a Growth Score of B.

The Estee Lauder Companies Inc. PEG Ratio (TTM)

See the full list of top ranked stocks here                                    

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>